TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive In Brief: Reagan Names Hammer to Third Term As Cancer Panel chairman; RPMI Opens Survivor Clinic July 31, 1987
TCL Archive One Year Later, Cancer Centers And NCI are Getting Along Just Fine, AACI Learns July 27, 1990
TCL Archive Panel Urges Research On DCIS To Identify Women At High Risk For Invasive Cancer September 25, 2009
TCL Archive NCI To Invite Unaffiliated Oncologists To Enroll Patients On Phase III Trials May 10, 2002
TCL Archive AAAS Urges Bush To Continue Funding For Stem Cell Research; ONS Hires Arent Fox. March 9, 2001
